Some TIR domains (including the TIR domain in SARM1) may therefore work together additively or synergistically for NAD+ cleavage in nerve and immune systems in response to several pathological settings related to not only degenerative diseases but also pathogen-related inflammatory diseases. The gene discussed is SARM1; the disease is neurodegenerative disease.